Northern Trust’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$888K Buy
168,814
+14,338
+9% +$329K ﹤0.01% 3464
2026
Q2
$6.8M Buy
154,476
+37,700
+32% +$1.51M ﹤0.01% 2437
2026
Q1
$4.68M Buy
116,776
+4,660
+4% +$178K ﹤0.01% 2484
2025
Q4
$4.61M Buy
112,116
+14,405
+15% +$546K ﹤0.01% 2521
2025
Q3
$2.87M Buy
97,711
+5,821
+6% +$127K ﹤0.01% 2834
2025
Q2
$1.59M Buy
91,890
+65,068
+243% +$853K ﹤0.01% 3120
2025
Q1
$281K Buy
+26,822
New +$438K ﹤0.01% 3817

Other funds holding SION

Northern Trust's SION Position: Q3 2026 in Review

Northern Trust increased its Sionna Therapeutics (SION) stake by 9.3% in Q3 2026, buying an estimated $329K and bringing the position to 168,814 shares worth $888K. The position accounts for ﹤0.01% of the portfolio, ranked #3464.

Northern Trust first reported a position in SION in Q1 2025 and has held it in 7 quarters since. The position peaked at $6.8M in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Northern Trust held 168,814 shares of Sionna Therapeutics worth $888K as of Q3 2026.
  • Northern Trust bought 14,338 Sionna Therapeutics shares in Q3 2026, an estimated $329K.
  • Sionna Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #3464 holding.
  • Northern Trust first reported a position in Sionna Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Northern Trust's Sionna Therapeutics position peaked at $6.8M in Q2 2026.
  • 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.